Literature DB >> 5776706

[Glybenclamide (HB 419): a new oral antidiabetic agent of the sulfonylurea group].

H Mehnert, E Karg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5776706     DOI： 10.1055/s-0028-1111124

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  11 in total

1.  Comparative study of the therapeutic effects of glibenclamide or the fixed combination of glibenclamide-phenformin with those of gliclazide or chlorpropamide.

Authors:  A E Raptis; N Tountas; A G Yalouris; D Hadjidakis; A Zaharis; K Miras; S A Raptis
Journal:  Acta Diabetol Lat       Date:  1990 Jan-Mar

2.  Progress in oral therapy of diabetes mellitus with sulphonylureas of the second generation.

Authors:  S Raptis; E F Pfeiffer
Journal:  Acta Diabetol Lat       Date:  1972 Nov-Dec

3.  [Recent findings in the use of 1st and 2nd generation hypoglycemic sulfonamides].

Authors:  K Schöffling; E Haupt; W Köberich; J Beyer
Journal:  Klin Wochenschr       Date:  1973-01-15

4.  [Non-indicated insulin treatment].

Authors:  B Knick; O Wendt; P Netter; M L Konder; B Friedel
Journal:  Acta Diabetol Lat       Date:  1970 May-Jun

5.  Controlled extension of oral antidiabetic therapy on former insulin dependent diabetics by means of the combined i.v. glibenclamide-glucose-response-test.

Authors:  E F Pfeiffer; S Raptis
Journal:  Diabetologia       Date:  1972-02       Impact factor: 10.122

6.  [Beta-cytotrophic action of glibenclamide on the pancreas of diabetic patients].

Authors:  J Rostlapil; M Zrůstová
Journal:  Acta Diabetol Lat       Date:  1972 Mar-Apr

7.  Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide. II. Repeated administration in combination with glucose.

Authors:  E Haupt; W Köberich; J Beyer; K Schöffling
Journal:  Diabetologia       Date:  1971-12       Impact factor: 10.122

8.  Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects.

Authors:  E Haupt; W Köberich; J Beyer; K Schöffling
Journal:  Diabetologia       Date:  1971-12       Impact factor: 10.122

9.  Insulin release by tolbutamide and glibenclamide. A comparative study on the perfused rat pancreas.

Authors:  H G Joost; A Hasselblatt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-04       Impact factor: 3.000

Review 10.  Drug interactions with oral sulphonylurea hypoglycaemic drugs.

Authors:  J M Hansen; L K Christensen
Journal:  Drugs       Date:  1977-01       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.